
Ysios Capital launches second fund
Ysios Capital has begun fundraising for Ysios BioFund II, a €100m life sciences vehicle.
According to unquote" data, the firm's first fund, Ysios BioFund I, launched in 2008 and held a first close on €67m that year. Minimum subscriptions were set at €1m with the GP contributing around 1% of the fund. The fund target stood at €65-75m; the VC raised €67m at final close.
Investments
Ysios BioFund II will back life sciences firms in the pharmaceutical, medical technology and diagnostics sectors. The vehicle will invest in up to 15 companies and will consider co-investment opportunities with international investors and corporate venture funds.
Investors
According to unquote" data, investors in Ysios's previous fund included financial institutions (47%) such as Kutxa, Banco Santander, LA Caixa, Banesto and Caja Murcia; SME development firms (21%) including Sociedad de Desarrollo de Navarra, Institut Català de Finances and Empresa Nacional de Innovación; family offices and private investors (16%) like the Bernat family office, Marmara Capital and JV Risk Technologies; and collective investment entities and other sources (16%) including Telefónica pension fund Fonditel.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater